Brief: Brii Biosciences Says NMPA Of China Granted Breakthrough Therapy Designations For Brii-877 And Brii-835
14/05/2024 24:23
May 14 (Reuters) - Brii Biosciences Ltd 2137.HK :
* NMPA OF CHINA GRANTED BREAKTHROUGH THERAPY DESIGNATIONS
FOR
BRII-877 AND BRII-835
Further company coverage: 2137.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR